|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 48 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2011-09-06 |
4 |
B |
$17.00 |
$30,285 |
I/I |
1,773 |
323,148 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-09-06 |
4 |
B |
$17.00 |
$2,206,641 |
I/I |
129,187 |
14,776,080 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-12-30 |
4 |
OE |
$6.25 |
$425,038 |
I/I |
68,006 |
539,130 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-12-30 |
4 |
OE |
$6.25 |
$2,219,644 |
I/I |
355,143 |
15,131,223 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-12-30 |
4 |
OE |
$6.25 |
$309,769 |
I/I |
49,563 |
450,461 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-12-30 |
4 |
OE |
$6.25 |
$2,123,675 |
I/I |
339,788 |
4,966,001 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2018-02-01 |
4 |
B |
$52.00 |
$199,999,956 |
I/I |
3,846,153 |
44,355,335 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$82,673 |
I/I |
6,576 |
323,576 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$410,220 |
I/I |
32,630 |
1,215,554 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$439,185 |
I/I |
34,934 |
1,691,130 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$51,658 |
I/I |
4,109 |
282,109 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-13 |
4 |
B |
$13.56 |
$45,572 |
I/I |
3,361 |
326,937 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-13 |
4 |
B |
$13.56 |
$226,166 |
I/I |
16,680 |
1,232,234 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-13 |
4 |
B |
$13.56 |
$242,152 |
I/I |
17,859 |
1,708,989 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-13 |
4 |
B |
$13.56 |
$28,474 |
I/I |
2,100 |
284,209 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-14 |
4 |
B |
$13.32 |
$34,978 |
I/I |
2,626 |
286,835 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-14 |
4 |
B |
$13.32 |
$55,971 |
I/I |
4,202 |
331,139 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-14 |
4 |
B |
$13.32 |
$277,722 |
I/I |
20,850 |
1,253,084 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-14 |
4 |
B |
$13.32 |
$297,329 |
I/I |
22,322 |
1,731,311 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-10-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(586,556) |
1,144,755 |
|
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-10-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
502,454 |
|
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2006-04-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,228,857 |
1,228,857 |
|
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2006-04-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,228,857) |
0 |
|
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2006-10-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(126,415) |
160,420 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2007-01-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(14,779) |
316,360 |
0 |
- |
|
1397 Records found
|
|
Page 48 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|